MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202647099631 A) filed by Imperial College Innovations on August 18, 2026, for Alpha-Synuclein Antibody.
Inventors include Aprile, Francesco Pctgb No; Gialama, Dimitra; Vadukul, Devkee; and Thrush, Rebecca Wo No.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: The invention relates to alpha-synuclein antibodies, and particularly, although not exclusively, to antibodies which target the P1 motif of alpha-synuclein. The invention extends to compositions comprising the antibodies, including pharmaceutical compositions and kits. The invention also extends to methods of making and using the antibodies, for example in therapy and diagnosis of neurodegenerative disorders, such as Parkinson's disease.
Disclaimer: Curated by HT Syndication.
